Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,769,389
+$33,865,092 QoQ
Shares Held
1,038,160
+139.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#55
of 1,348 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $2,915,385,555 across 19 Drug Manufacturers - General names. NVO ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
746,099 | $894,893,598 | |
| 2 | JNJ |
Johnson & Johnson
|
1,814,780 | $460,899,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,548,737 | $327,512,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,670,876 | $316,831,506 | |
| 5 | NVS |
Novartis AG
|
1,974,043 | $309,372,018 | |
| 6 | ABBV |
AbbVie Inc.
|
988,813 | $248,824,903 | |
| 7 | PFE |
Pfizer Inc
|
4,638,683 | $111,699,485 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
502,809 | $63,524,888 |
All Filings in NVO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,769,389 | 1,038,160 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,904,297 | 432,770 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,726,585 | 151,859 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,317,117 | 149,885 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,377,608 | 135,868 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,543,961 | 108,640 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $6,197,912 | 72,052 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,308,378 | 44,582 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,141,849 | 22,011 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $676,282 | 5,267 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $43,862 | 424 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $43,651 | 480 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,518 | 65 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $17,027 | 107 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $22,195 | 164 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,944 | 150 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $20,614 | 185 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $20,988 | 189 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $71,568 | 639 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $47,524 | 495 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $41,466 | 495 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $33,372 | 495 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $25,215 | 361 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||